Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07039617 · ClinicalTrials.gov registry record · NA

AIDANET At Home Study

A NA study of Type 1 Diabetes, sponsored by Sue Brown.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07039617 is a NA study of Type 1 Diabetes that is actively recruiting participants, run by Sue Brown. The registered enrollment target is 40 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07039617, a NA study of Type 1 Diabetes, is actively recruiting participants, sponsored by Sue Brown.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

A randomized cross-over trial assessing glycemic control on Automated insulin delivery as Adaptive Network (AIDANET) algorithm when used in three modes: AIDANET-Fully Closed Loop (FCL), AIDANET-Hybrid Closed Loop (HCL) and AIDANET allowing a mix between FCL and HCL. There will be an Automated Insulin Delivery (AID) phase with participants using their home devices and/or study continuous glucose monitor (CGM) and study-provided commercial Mobi system without AIDANET.

Conditions Studied

Interventions

  • DEVICE AIDANET + FCL
  • DEVICE AIDANET + HCL
  • DEVICE AIDANET in FCL-HCL-mixed mode
  • OTHER Automated Insulin Delivery (AID) (usual care)

Study Locations (1)

Virginia

  • University of Virginia Center for Diabetes Technology - Charlottesville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-02
Est. Completion 2026-07-31
Phase NA

Sponsor

Sue Brown

6 total trials

What the Registry Record Tells You About NCT07039617

The ClinicalTrials.gov registry entry for NCT07039617 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The listed sponsor is Sue Brown, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 4 interventions - of which AIDANET + FCL is the first listed.

NCT07039617 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT07039617 about?

NCT07039617 is a clinical study titled "AIDANET At Home Study". A randomized cross-over trial assessing glycemic control on Automated insulin delivery as Adaptive Network (AIDANET) algorithm when used in three modes: AIDANET-Fully Closed Loop (FCL), AIDANET-Hybrid Closed Loop (HCL) and AIDANET allowing a mix between FCL and HCL. There will be an Automated Insuli...

What is the current status of trial NCT07039617?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-02. Estimated completion is 2026-07-31.

What conditions does trial NCT07039617 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT07039617?

The interventions under investigation include: AIDANET + FCL (DEVICE), AIDANET + HCL (DEVICE), AIDANET in FCL-HCL-mixed mode (DEVICE), Automated Insulin Delivery (AID) (usual care) (OTHER).

Who is sponsoring clinical trial NCT07039617?

This trial is sponsored by Sue Brown, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07039617 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.